insights_auto
Why is 8QQ down 8.90%?
Dive Deeperchevron_right
8QQ:FRA
AbCellera Biologics Inc
€10.44
arrow_downward
-8.90%(-1.02) 1D
Oct 9, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 8QQ...
Open
€10.70
High
€10.70
Low
€10.44
Mkt. cap
4.06B
Avg. vol.
436.00
Volume
700.00
52-wk high
€12.96
52-wk low
€2.49
No. of employees
562
Open
€10.70
High
€10.70
Low
€10.44
Mkt. cap
4.06B
Avg. vol.
436.00
Volume
700.00
52-wk high
€12.96
52-wk low
€2.49
No. of employees
562
News stories
From web sources and news partners
Simply Wall Street
·
1 day ago
Clinical Data Update Might Change The Case For Investing In AbCellera Biologics Stock
Profile
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
About AbCellera Biologics Inc
CEOCarl Hansen
Employees562
Founded2012
HeadquartersVancouver, British Columbia, Canada
SectorHealth care
Websiteabcellera.com